Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Obesity × dapagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 4 Obesity 1 Breast Neoplasms 1

Interventions

Metformin 3 Exenatide 2 semaglutide 1 lime 1 dapagliflozin 1 Taxes 1 Tamoxifen 1 Sugammadex 1 Sodium-Glucose Transporter 2 Inhibitors 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Qsymia 1 Paclitaxel 1 Liraglutide 1 Letrozole 1 Immunoenzyme Techniques 1 Glucagon-Like Peptide 1 1 Early Intervention, Educational 1 Diazoxide 1 Counseling 1 Carboplatin 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed

119 enrolled 34 charts

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡